Schmidt, Timothy M. http://orcid.org/0000-0002-5860-2640
Article History
Received: 3 April 2024
Revised: 11 May 2024
Accepted: 15 May 2024
First Online: 4 June 2024
Competing interests
: TMS has served as a consultant for BiolineRx, Janssen, and Sanofi, and has received institutional research funding for clinical trials from Alexion Pharmaceuticals, Bristol-Myers Squibb, and Janssen.